Purdue Pharma Expected To File Bankruptcy Amid Settlement Negotiations "Hitting An Impasse" | WHAT REALLY HAPPENED

Purdue Pharma Expected To File Bankruptcy Amid Settlement Negotiations "Hitting An Impasse"

The makers of Oxycontin, Purdue Pharma, are now expected to file for bankruptcy after settlement talks regarding the nation's opioid crisis have "hit an impasse", according to ABC News.

This impasse puts Purdue's federal trial over the opioid epidemic on track to start next month and sets the stage for significant legal drama involving state and local governments.

Purdue had been working for months to try and avoid trial by determining the company's responsibility for the crisis, which has cost over 400,000 Americans their lives. But an email from the attorneys general of Tennessee and North Carolina revealed that Purdue and the Sackler family had rejected two offers from the states over how payments would be handled as a result of a settlement.

Tennessee Attorney General Herbert Slatery and North Carolina Attorney General Josh Stein wrote in their message:

"As a result, the negotiations are at an impasse, and we expect Purdue to file for bankruptcy protection imminently."

The Sackler family is being sued separately in at least 17 states, and its unclear what the bankruptcy means for them. Meanwhile, the family is believed to have transferred most of its multi-billion dollar fortune overseas.

Pennsylvania Attorney General Josh Shapiro says he will now sue the Sackler family, as other states have:

"I think they are a group of sanctimonious billionaires who lied and cheated so they could make a handsome profit," he said. "I truly believe that they have blood on their hands."

Webmaster's Commentary: 

GOOD!!

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA